Phase II trial of PS-341 in patients with renal cell cancer: a University of Chicago phase II consortium study. - Davis,N.B.; Taber,D.A.; Ansari,R.H.; Ryan,C.W.; George,C.; Vokes,E.E.; Vogelzang,N.J.; Stadler,W.M. (J Clin Oncol, 2004)